{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:12:16Z","timestamp":1769829136682,"version":"3.49.0"},"reference-count":36,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:00:00Z","timestamp":1616803200000},"content-version":"unspecified","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"AGMEN","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,3,2]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Assessment of response to therapy in paediatric patients with Hodgkin lymphoma (HL) by 18F-fluorodeoxyglucose positron emission tomography\/CT has become a powerful tool for the discrimination of responders from non-responders. The addition of volumetric and texture analyses can be regarded as a valuable help for disease prognostication and biological characterisation. Based on these premises, the Hodgkin Lymphoma Study Group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) has designed a prospective evaluation of volumetric and texture analysis in the Italian cohort of patients enrolled in the EuroNet-PHL-C2.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>The primary objective is to compare volumetric assessment in patiens with HL at baseline and during the course of therapy with standard visual and semiquantitative analyses. The secondary objective is to identify the impact of volumetric and texture analysis on bulky masses. The tertiary objective is to determine the additional value of multiparametric assessment in patients having a partial response on morphological imaging.<\/jats:p>\n                  <jats:p>The overall cohort of the study is expected to be round 400\u2013500 patients, with approximately half presenting with bulky masses. All PET scans of the Italian cohort will be analysed for volumetric assessment, comprising metabolic tumour volume and total lesion glycolysis at baseline and during the course of therapy. A dedicated software will delineate semiautomatically contours using different threshold methods, and the impact of each segmentation techniques will be evaluated. Bulky will be defined on contiguous lymph node masses \u2265200\u2009mL on CT\/MRI. All bulky masses will be outlined and analysed by the same software to provide textural features. Morphological assessment will be based on RECIL 2017 for response definition.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The current study has been ethically approved (AIFA\/SC\/P\/27087 approved 09\/03\/2018; EudraCT 2012-004053-88, EM-04). The results of the different analyses performed during and after study completion the will be actively disseminated through peer-reviewed journals, conference presentations, social media, print media and internet.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-041252","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T11:20:29Z","timestamp":1617016829000},"page":"e041252","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Additional value of volumetric and texture analysis on FDG PET assessment in paediatric Hodgkin lymphoma: an Italian multicentric study protocol"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-1094","authenticated-orcid":false,"given":"Egesta","family":"Lopci","sequence":"first","affiliation":[{"name":"Nuclear Medicine Department, IRCCS - Humanitas Research Hospital, Rozzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Burnelli","sequence":"additional","affiliation":[{"name":"Pediatric Onco-hematologic Unit, University Hospital Arcispedale Sant\u2019Anna of Ferrara, Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Elia","sequence":"additional","affiliation":[{"name":"AYA Oncology and Pediatric Radiotherapy Unit, Centro di Riferimento Oncologico, Aviano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnoldo","family":"Piccardo","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Ente Ospedaliero Ospedali Galliera, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Castello","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, IRCCS - Humanitas Research Hospital, Rozzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Borsatti","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Centro di Riferimento Oncologico, Aviano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Zucchetta","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Padua University Hospital, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelina","family":"Cistaro","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Ente Ospedaliero Ospedali Galliera, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Mascarin","sequence":"additional","affiliation":[{"name":"AYA Oncology and Pediatric Radiotherapy Unit, Centro di Riferimento Oncologico, Aviano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"2025101811353118000_11.3.e041252.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"2025101811353118000_11.3.e041252.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"2025101811353118000_11.3.e041252.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3690-8"},{"key":"2025101811353118000_11.3.e041252.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2715-9"},{"key":"2025101811353118000_11.3.e041252.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.9381"},{"key":"2025101811353118000_11.3.e041252.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4432-4","article-title":"Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin\u2019s lymphoma","volume":"18","author":"Rogasch","year":"2018","journal-title":"BMC Cancer"},{"key":"2025101811353118000_11.3.e041252.7","first-page":"20","article-title":"Fdg-Pet imaging for Hodgkin lymphoma: current use and future applications","volume":"12","author":"Kostakoglu","year":"2014","journal-title":"Clin Adv Hematol Oncol"},{"key":"2025101811353118000_11.3.e041252.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2705-y"},{"key":"2025101811353118000_11.3.e041252.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2783-x"},{"key":"2025101811353118000_11.3.e041252.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116574","article-title":"Low-order non-spatial effects dominate second-order spatial effects in the texture quantifier analysis of 18F-FDG-PET images","volume":"10","author":"Brooks","year":"2015","journal-title":"PLoS One"},{"key":"2025101811353118000_11.3.e041252.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.163469"},{"key":"2025101811353118000_11.3.e041252.12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.semnuclmed.2017.01.001","article-title":"Current role of FDG-PET in pediatric Hodgkin\u2019s lymphoma","volume":"47","author":"Kluge","year":"2017","journal-title":"Semin Nucl Med"},{"key":"2025101811353118000_11.3.e041252.13","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1002\/mp.12349","article-title":"Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas","volume":"44","author":"Ben Bouall\u00e8gue","year":"2017","journal-title":"Med Phys"},{"key":"2025101811353118000_11.3.e041252.14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-37197-z","article-title":"A PET Radiomics model to predict refractory mediastinal Hodgkin lymphoma","volume":"9","author":"Milgrom","year":"2019","journal-title":"Sci Rep"},{"key":"2025101811353118000_11.3.e041252.15","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00259-011-1836-7","article-title":"Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin\"s disease","volume":"38","author":"Lopci","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025101811353118000_11.3.e041252.16","first-page":"S155","article-title":"Additional role of FDG-PET in paediatric HD patients presenting with a partial response on CT: data deriving from a multicentric Italian study","volume":"39","author":"Lopci","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025101811353118000_11.3.e041252.17","unstructured":"Second international inter-group study for classical hodgkin lymphoma in children and adolescents. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02684708"},{"key":"2025101811353118000_11.3.e041252.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.093443"},{"key":"2025101811353118000_11.3.e041252.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1297-4"},{"key":"2025101811353118000_11.3.e041252.20","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1002\/mp.12349","article-title":"Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas","volume":"44","author":"Ben Bouall\u00e8gue","year":"2017","journal-title":"Med Phys"},{"key":"2025101811353118000_11.3.e041252.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210047"},{"key":"2025101811353118000_11.3.e041252.22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-795476"},{"key":"2025101811353118000_11.3.e041252.23","first-page":"1342","article-title":"Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer","volume":"46","author":"Nestle","year":"2005","journal-title":"J Nucl Med"},{"key":"2025101811353118000_11.3.e041252.24","first-page":"S156","article-title":"A software for characterizing intra-tumor heterogeneity in multimodality imaging and establishing reference charts","volume":"43","author":"Nioche","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025101811353118000_11.3.e041252.25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12149-018-1260-1","article-title":"18\n               F-FDG PET\/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin\"s lymphoma as predictors of treatment outcome and survival","volume":"32","author":"Parvez","year":"2018","journal-title":"Ann Nucl Med"},{"key":"2025101811353118000_11.3.e041252.26","doi-asserted-by":"crossref","unstructured":"Castello A , Russo C , Grizzi F . Prognostic impact of intratumoral heterogeneity based on fractal geometry analysis in operated NSCLC patients. Mol Imaging Biol 2018:965\u201372.","DOI":"10.1007\/s11307-018-1299-3"},{"key":"2025101811353118000_11.3.e041252.27","doi-asserted-by":"crossref","unstructured":"Grizzi F , Castello A , Qehajaj D . The complexity and fractal geometry of nuclear medicine images. Mol Imaging Biol 2018:401\u20139.","DOI":"10.1007\/s11307-018-1236-5"},{"key":"2025101811353118000_11.3.e041252.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.129858"},{"key":"2025101811353118000_11.3.e041252.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-016-4470-8"},{"key":"2025101811353118000_11.3.e041252.30","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx097"},{"key":"2025101811353118000_11.3.e041252.31","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12282"},{"key":"2025101811353118000_11.3.e041252.32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-773838"},{"key":"2025101811353118000_11.3.e041252.33","doi-asserted-by":"publisher","DOI":"10.1186\/s41747-018-0068-z"},{"key":"2025101811353118000_11.3.e041252.34","doi-asserted-by":"publisher","DOI":"10.1007\/PL00008340"},{"key":"2025101811353118000_11.3.e041252.35","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","article-title":"PET-guided treatment in patients with advanced-stage Hodgkin\u2019s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group","volume":"390","author":"Borchmann","year":"2017","journal-title":"Lancet"},{"key":"2025101811353118000_11.3.e041252.36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(18)30784-8","article-title":"PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study","volume":"20","author":"Casasnovas","year":"2019","journal-title":"Lancet Oncol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-041252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:35:38Z","timestamp":1760812538000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-041252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,29]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/bmjopen-2020-041252"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-041252","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}